Prakash Chinnaiyan MD
Assistant Professor, Oncologic Sciences, USF-Morsani
Join to View Full Profile
3577 W 13 Mile RdRoyal Oak, MI 48073
Phone+1 248-551-7020
Fax+1 248-551-1199
Are you Dr. Chinnaiyan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Prakash Chinnaiyan, MD is a radiation oncologist in Royal Oak, Michigan. He is currently licensed to practice medicine in Michigan, Florida, and Wisconsin. He is an Assistant Professor at USF-Morsani.
Education & Training
University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 2001 - 2006
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 2000 - 2001
Wayne State University School of MedicineClass of 2000
Certifications & Licensure
MI State Medical License 2014 - 2025
FL State Medical License 2006 - 2017
WI State Medical License 2004 - 2007
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- The RAGE Inhibitor TTP488 (Azeliragon) Demonstrates Anti-Tumor Activity and Enhances the Efficacy of Radiation Therapy in Pancreatic Cancer Cell Lines.Kumari Alka, Jacob F Oyeniyi, Ghulam Mohammad, Yi Zhao, Stephen Marcus
Cancers. 2024-12-24 - 5 citationsMetabolomic Profiles of Human Glioma Inform Patient Survival.Andrew J Scott, Luis O Correa, Donna M Edwards, Yilun Sun, Visweswaran Ravikumar
Antioxidants & Redox Signaling. 2023-11-01 - 23 citationsQuinolinate promotes macrophage-induced immune tolerance in glioblastoma through the NMDAR/PPARγ signaling axis.Pravin Kesarwani, Shiva Kant, Yi Zhao, Antony Prabhu, Katie L Buelow
Nature Communications. 2023-03-16
Press Mentions
New Research May Hold Key to Better Treatments for Aggressive Brain CancerApril 18th, 2023- Year-in-Review: OUWB Reaccreditation, COVID-19 Among Top Stories for 2020December 27th, 2020
OUWB Professor, Researcher Awarded $1.6 Million Grant to Study Deadly Brain TumorsJanuary 29th, 2020- Join now to see all
Grant Support
- Quinolinate-induced immune suppression in glioblastomaWILLIAM BEAUMONT HOSPITAL RESEARCH INST2023–2028
- Quinolinate-induced immune suppression in glioblastomaWILLIAM BEAUMONT HOSPITAL RESEARCH INST2023–2028
- Quinolinate-induced immune suppression in glioblastomaWILLIAM BEAUMONT HOSPITAL RESEARCH INST2023–2028
- Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastomaWILLIAM BEAUMONT HOSPITAL RESEARCH INST2019–2025
